What's in Universita degli Studi di Genova's pipeline?

Universita degli Studi di Genova has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Universita degli Studi di Genova's portfolio?

Top competitors by shared drug class: Boston Medical Center, Far Eastern Memorial Hospital, Medical College of Wisconsin, Norwegian University of Science and Technology, Rabin Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universita-degli-studi-di-genova.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Universita degli Studi di Genova — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Universita degli Studi di Genova pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Amoxicillin Long	Amoxicillin Long	marketed
Amoxicillin Short	Amoxicillin Short	marketed	Beta-lactam antibiotic (aminopenicillin)	Penicillin-binding proteins (PBPs)	Infectious Disease

Therapeutic area mix

Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Boston Medical Center · 1 shared drug class
Far Eastern Memorial Hospital · 1 shared drug class
Medical College of Wisconsin · 1 shared drug class
Norwegian University of Science and Technology · 1 shared drug class
Rabin Medical Center · 1 shared drug class
The Third Xiangya Hospital of Central South University · 1 shared drug class
University Hospital, Montpellier · 1 shared drug class
Western Galilee Hospital-Nahariya · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universita degli Studi di Genova:

Cite this brief

Drug Landscape (2026). Universita degli Studi di Genova — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universita-degli-studi-di-genova. Accessed 2026-05-17.